Calliditas Therapeutics AB - ADR

NASDAQ:CALT  
31.01
+1.33 (+4.48%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Calliditas Therapeutics AB - ADR Stock, NASDAQ:CALT

Kungsbron 1, C8, Stockholm, Stockholm 111 22
Sweden
Phone: +46.8.411.3005
Number of Employees: 34

Description

Calliditas Therapeutics AB clinical-stage biopharmaceutical company. It engages in the identification, development, and commercialization of novel treatments in orphan indications. The firm focuses on renal and hepatic diseases with significant unmet medical needs. It offers Nefecon, a proprietary, novel oral formulation of budesonide for the treatment of the autoimmune renal disease IgA nephropathy, or IgAN. The company was founded by Mikael Bender and Bengt ??ke Julander on February 20, 2004 and is headquartered in Stockholm, Sweden.